16-30957268-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000710314.1(SETD1A):​c.-712C>T variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.527 in 151,918 control chromosomes in the GnomAD database, including 23,474 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.53 ( 23458 hom., cov: 32)
Exomes 𝑓: 0.73 ( 16 hom. )

Consequence

SETD1A
ENST00000710314.1 upstream_gene

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.01

Publications

24 publications found
Variant links:
Genes affected
SETD1A (HGNC:29010): (SET domain containing 1A, histone lysine methyltransferase) The protein encoded by this gene is a component of a histone methyltransferase (HMT) complex that produces mono-, di-, and trimethylated histone H3 at Lys4. Trimethylation of histone H3 at lysine 4 (H3K4me3) is a chromatin modification known to generally mark the transcription start sites of active genes. The protein contains SET domains, a RNA recognition motif domain and is a member of the class V-like SAM-binding methyltransferase superfamily. [provided by RefSeq, Dec 2016]
SETD1A Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • neurodevelopmental disorder with speech impairment and dysmorphic facies
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • epilepsy, early-onset, with or without developmental delay
    Inheritance: Unknown, AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000710314.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.883 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000710314.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SETD1A
ENST00000710314.1
c.-712C>T
upstream_gene
N/AENSP00000518195.1O15047
ENSG00000275263
ENST00000614997.1
TSL:6
n.-69G>A
upstream_gene
N/A

Frequencies

GnomAD3 genomes
AF:
0.527
AC:
80025
AN:
151744
Hom.:
23444
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.272
Gnomad AMI
AF:
0.630
Gnomad AMR
AF:
0.570
Gnomad ASJ
AF:
0.691
Gnomad EAS
AF:
0.905
Gnomad SAS
AF:
0.308
Gnomad FIN
AF:
0.668
Gnomad MID
AF:
0.737
Gnomad NFE
AF:
0.626
Gnomad OTH
AF:
0.593
GnomAD4 exome
AF:
0.732
AC:
41
AN:
56
Hom.:
16
Cov.:
0
AF XY:
0.650
AC XY:
26
AN XY:
40
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AF:
0.500
AC:
1
AN:
2
European-Finnish (FIN)
AF:
0.900
AC:
9
AN:
10
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.705
AC:
31
AN:
44
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.527
AC:
80085
AN:
151862
Hom.:
23458
Cov.:
32
AF XY:
0.528
AC XY:
39223
AN XY:
74230
show subpopulations
African (AFR)
AF:
0.272
AC:
11271
AN:
41390
American (AMR)
AF:
0.570
AC:
8690
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.691
AC:
2392
AN:
3462
East Asian (EAS)
AF:
0.905
AC:
4658
AN:
5146
South Asian (SAS)
AF:
0.310
AC:
1492
AN:
4808
European-Finnish (FIN)
AF:
0.668
AC:
7056
AN:
10562
Middle Eastern (MID)
AF:
0.741
AC:
218
AN:
294
European-Non Finnish (NFE)
AF:
0.626
AC:
42495
AN:
67932
Other (OTH)
AF:
0.589
AC:
1240
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
1670
3340
5011
6681
8351
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
674
1348
2022
2696
3370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.576
Hom.:
6774
Bravo
AF:
0.518
Asia WGS
AF:
0.546
AC:
1902
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
1.0
DANN
Benign
0.95
PhyloP100
-1.0
PromoterAI
-0.051
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs4889599;
hg19: chr16-30968589;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.